QR-kod

Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease

Abstract Introduction Deutetrabenazine is a vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia (TD) and chorea associated with Huntington disease (HD). To enhance detection of safety signals across individual trials, integrated safety analyses of deutetrabenazine in TD and...

Full beskrivning

Sparad:
Huvudupphov: Samuel Frank, Karen E. Anderson, Hubert H. Fernandez, Robert A. Hauser, Daniel O. Claassen, David Stamler, Stewart A. Factor, Joohi Jimenez-Shahed, Hadas Barkay, Amanda Wilhelm, Jessica K. Alexander, Nayla Chaijale, Steve Barash, Juha-Matti Savola, Mark Forrest Gordon, Maria Chen
Materialtyp: Artigo
Språk:Inglês
Utgiven: Adis, Springer Healthcare 2024-04-01
Serie:Neurology and Therapy
Ämnen:
Chorea
Deutetrabenazine
Huntington disease
Movement disorders
Safety profile
Tardive dyskinesia
Länkar:https://doi.org/10.1007/s40120-024-00600-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk